A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis

Robert J. Arceci, Carl E. Allen, Ira J. Dunkel, Eric Jacobsen, James Whitlock, Robert Vassallo, Shannon R. Morris, Alison Portnoy, Beth Ann Reedy, Deborah A. Smith, Robert Noble, Amy Murnane, Mark Cornfeld, Carlos Rodriguez-Galindo, Mark L. Heaney, Kenneth McClain, Sarah Vaiselbuh

Research output: Contribution to journal › Article › peer-review